SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alliance Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ubrx who wrote (342)4/15/1999 6:20:00 PM
From: Alok Sinha   of 548
 
All the three products Oxygent, Liquivent and Impagent are in Phase III. Imagent is the farthest along with an NDA expected late summer , early fall. Enrollment for Oxygent Phase II in Europe started last Dec, US enrollment may start in the next couple of months. Liquivent enrollment should be complete later this year.

I don't think dilution means much for a $2.5 stock. I recall the last time ALLP did a secondary offering, the stock actually went up when they went on a road show.

Regards

Alok
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News